Article

jdsupra.comjdsupra.com on 2018-09-04 22:42

Rx IP Update - August 2018

Teva succeeds in section 8 bortezomib action; infringement counterclaim dismissed - On July 18, 2018, Justice Locke of the Federal Court ...

Related news